SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5xrf'

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 9	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.58A	1bcuH-5xrfA: 15.3	1bcuH-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	6 / 12	HIS A  67 ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.67A	1etrH-5xrfA: 29.7	1etrH-5xrfA: 13.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 8	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.70A	1f5lA-5xrfA: 9.9	1f5lA-5xrfA: 15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TNL_A_TPAA900_1 (TRYPSIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 6	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.66A	1tnlA-5xrfA: 13.3	1tnlA-5xrfA: 11.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X7P_B_SAMB302_0 (RRNA METHYLTRANSFERASE)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 10	THR A 201 GLY A 148 GLY A 150 ILE A 199 ALA A 166	None	1.03A	1x7pA-5xrfA: undetectable 1x7pB-5xrfA: undetectable	1x7pA-5xrfA: undetectable 1x7pB-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2NV4_B_SAMB202_0 (UPF0066 PROTEIN AF_0241)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 12	ALA A  40 GLN A  82 PRO A 163 GLY A 150 LEU A 159	None	1.35A	2nv4B-5xrfA: undetectable	2nv4B-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 6	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.63A	2otvA-5xrfA: 13.5	2otvA-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	6 / 12	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234 TYR A 236	None	0.65A	2p16A-5xrfA: 11.8	2p16A-5xrfA: 14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	6 / 12	ASP A 200 SER A 206 VAL A 220 GLY A 223 GLY A 234 TYR A 236	None	0.57A	2w26A-5xrfA: 10.9	2w26A-5xrfA: 14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	5 / 11	HIS A  67 ASP A 200 SER A 206 GLY A 223 GLY A 234	None	0.69A	3gy3A-5xrfA: 13.3	3gy3A-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 6	SER A 206 VAL A 220 GLY A 223 GLY A 234	None	0.63A	3rxfA-5xrfA: 14.6	3rxfA-5xrfA: 12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 5	ASP A 200 SER A 206 VAL A 220 GLY A 234	None	0.60A	3rxhA-5xrfA: 13.4	3rxhA-5xrfA: 12.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TPX_C_ACTC207_0 (E3 UBIQUITIN-PROTEIN LIGASE MDM2)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 4	LYS A 120 PRO A 121 LEU A 118 ASN A 119	None	1.50A	3tpxC-5xrfA: undetectable	3tpxC-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1478_0 (TRANSLATION ELONGATION FACTOR SELB)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 7	ASP A 205 GLY A  54 THR A  55 THR A 201	None	0.86A	4acaC-5xrfA: undetectable	4acaC-5xrfA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N09_C_ADNC401_2 (ADENOSINE KINASE)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 5	ASN A 169 LEU A 171 SER A 142 LEU A 190	None	1.22A	4n09C-5xrfA: undetectable	4n09C-5xrfA: 12.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KB5_A_ADNA401_2 (ADENOSINE KINASE)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 4	ASN A 169 LEU A 171 SER A 142 LEU A 190	None	1.16A	5kb5A-5xrfA: undetectable	5kb5A-5xrfA: 12.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UMW_B_RBFB201_1 (GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE)	5xrf	SNAKE VENOM SERINE PROTEASE DA-36 (Deinagkistrodon acutus)	4 / 7	VAL A 114 ARG A  71 GLU A  97 ARG A 101	None	1.02A	5umwB-5xrfA: undetectable 5umwE-5xrfA: undetectable	5umwB-5xrfA: 20.69 5umwE-5xrfA: 20.69